Unclassified · NSE: HDFCLIFE
HDFC Life Insurance share analysis
Fair value, business quality, the case for and against, and the risks — computed by VestCall from reported data, updated 14 October 2026.
HDFC Life Insurance in one paragraph
HDFC Life Insurance (NSE: HDFCLIFE) was trading at ₹552.4 on 14 October 2026. VestCall scores its business health 42/100 (weak). On valuation, the price sits in the “Valuation Premium” zone (₹538.48 and above) — above the modelled fair-value range. This is a reading of the evidence, not a buy or sell recommendation.
- Share price₹552.4
- Business health42/100
- Growth44/100
- Financial strength64/100
- Valuation91/100 · Fair
- Valuation zoneValuation Premium
- RiskMedium
Is HDFC Life Insurance overvalued or undervalued?
At ₹552.4, HDFC Life Insurance sits in VestCall’s “Valuation Premium” zone (₹538.48 and above): above the modelled fair-value range. Its valuation scores 91/100 (fair) against Unclassified peers. Zones describe where the price sits against modelled value; they are not an instruction to buy or sell.
| Valuation zone | Price band | What it means |
|---|---|---|
| Deeply Discounted | ₹480.91 – ₹510.05 | Furthest below the modelled fair-value range |
| Attractive Valuation | ₹510.05 – ₹523.53 | Below the modelled fair-value range |
| Fairly Valued | ₹523.53 – ₹538.48 | Inside the modelled fair-value range |
| Valuation Premium (current) | ₹538.48 and above | Above the modelled fair-value range |
The case for and against HDFC Life Insurance
What supports the case
- Shareholding Quality · 87/100.
- Financial Strength · 64/100.
- Management Stability · 64/100.
What needs proof
- Growth · 13/100.
- Business Quality · 26/100.
HDFC Life Insurance key ratios
| Ratio | HDFC Life Insurance | Unclassified median |
|---|---|---|
| P/E | 2.25x | — |
| P/S | 2.51x | — |
| Operating margin | 2.3% | — |
| Net margin | 2.5% | — |
| Current ratio | 1.03x | — |
HDFC Life Insurance growth
Growth scores 44/100, with a positive trend, measured Mar 2023 to Mar 2026.
| Measure | Reading |
|---|---|
| Revenue CAGR | -12.1% |
| Net profit CAGR | -3.2% |
| EPS CAGR | 9.0% |
| Revenue growth, latest year | -31.7% |
| Profit growth, latest year | 19.0% |
HDFC Life Insurance bull, base and bear case
Modelled annual return under three sets of stated assumptions over 5 years. These are model outputs, not a forecast or a promise of return.
| Scenario | Modelled CAGR | Weight | Assumption |
|---|---|---|---|
| Bear | −4.1% | 21% | Growth decelerates to -0.1% and the multiple de-rates toward the cohort's trough. |
| Base | +4.7% | 54% | Earnings compound near the measured 4.7% and the multiple drifts toward its quality-adjusted warranted level. |
| Bull | +11.2% | 25% | Growth holds at 7.7% and the market pays the full premium the measured quality supports. |
Risks to watch in HDFC Life Insurance
| Review trigger | Current | Threshold | Status |
|---|---|---|---|
| Revenue growth falls below the thesis floor | -12.08% | below 8% | high · breached |
| Drawdown from the 52-week high exceeds tolerance | 29.86% | at or beyond 25% | low · breached |
| Promoter holding drops materially | 50.54% | below 47.54%, 3 points under the Mar 2026 filing | high · armed |
| Price runs more than two sigma above its own trend | 552.4 | at or above 871.32 | medium · armed |
| Return on equity falls below the quality floor | ROE not reported | below 15% | high · unmeasurable |
| Leverage doubles from the level underwritten today | No leverage line in the balance sheet | unavailable | high · unmeasurable |
| Promoter pledge rises above tolerance | No pledge disclosed (the NSE filing for HDFCLIFE could not be read either (nse_session_unavailable)) | above 10% | high · unmeasurable |
| Valuation reaches the top of its own cohort | No cohort multiple to rank against | at or above the 95th percentile | medium · unmeasurable |
An armed trigger is watched and has not fired; a breached one has.
How HDFC Life Insurance shares have traded
| Measure | Reading |
|---|---|
| 52-week range | ₹514 – ₹787.55 |
| Distance from 52-week high | −29.9% |
| Return, 3 months | −0.5% |
| Return, 12 months | −27.6% |
| Trend | Downtrend |
| Annualised volatility | 23.4% |
| Deepest drawdown, 2 years | −36.9% |
Questions about HDFC Life Insurance shares
Is HDFC Life Insurance overvalued or undervalued?
At ₹552.4, HDFC Life Insurance sits in VestCall’s “Valuation Premium” zone (₹538.48 and above): above the modelled fair-value range. Its valuation scores 91/100 (fair) against Unclassified peers. Zones describe where the price sits against modelled value; they are not an instruction to buy or sell.
Is HDFC Life Insurance fundamentally strong?
VestCall scores HDFC Life Insurance’s business health 42/100 (weak). The strongest measured pillars are shareholding quality and financial strength. The ones that need proof are growth and business quality. Each pillar is computed from reported financials, and a pillar whose inputs were not reported is excluded rather than scored as zero.
What is HDFC Life Insurance’s P/E ratio?
HDFC Life Insurance trades at a P/E of 2.25x, on VestCall’s latest read. A multiple only means something against the business it buys: the quality-adjusted fair value on this page weighs it against HDFC Life Insurance’s returns and growth.
What are the risks of investing in HDFC Life Insurance?
The review triggers VestCall watches for HDFC Life Insurance are: revenue growth falls below the thesis floor (revenue cagr below 8%); drawdown from the 52-week high exceeds tolerance (drawdown from 52-week high at or beyond 25%); promoter holding drops materially (promoter holding below 47.54%, 3 points under the Mar 2026 filing). On the fundamentals, growth is the weakest measured pillar at 13/100. A trigger is a named condition that would change the reading, published so the case against the stock is as visible as the case for it.
Is this a recommendation to buy or sell HDFC Life Insurance?
No. VestCall states where HDFC Life Insurance’s price sits against modelled value, what supports the case and what would break it, with every figure sourced. It does not issue buy, sell or hold calls or price targets. Vestmind is not a SEBI-registered investment adviser or research analyst, and nothing on this page is personalised investment advice.
Compare with other companies in Financial Services
Read the full HDFC Life Insurance analysis
Every score opens into its signals, the valuation into its anchors and workings, and the statements are one click away. Free, no account needed.